Deutsche Bank’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.7K | Buy |
2,938
+813
| +38% | +$1.3K | ﹤0.01% | 3508 |
|
2025
Q1 | $2.59K | Buy |
2,125
+1,419
| +201% | +$1.73K | ﹤0.01% | 3500 |
|
2024
Q4 | $1.33K | Sell |
706
-6,626
| -90% | -$12.5K | ﹤0.01% | 3509 |
|
2024
Q3 | $39.2K | Hold |
7,332
| – | – | ﹤0.01% | 3348 |
|
2024
Q2 | $54.1K | Buy |
7,332
+6,819
| +1,329% | +$50.3K | ﹤0.01% | 3271 |
|
2024
Q1 | $6.13K | Sell |
513
-1
| -0.2% | -$12 | ﹤0.01% | 3485 |
|
2023
Q4 | $4.01K | Hold |
514
| – | – | ﹤0.01% | 3504 |
|
2023
Q3 | $2.26K | Sell |
514
-2,662
| -84% | -$11.7K | ﹤0.01% | 3572 |
|
2023
Q2 | $111K | Sell |
3,176
-1,787
| -36% | -$62.2K | ﹤0.01% | 3220 |
|
2023
Q1 | $108K | Buy |
4,963
+2,405
| +94% | +$52.4K | ﹤0.01% | 3285 |
|
2022
Q4 | $55.3K | Buy |
2,558
+40
| +2% | +$864 | ﹤0.01% | 3513 |
|
2022
Q3 | $61K | Sell |
2,518
-396
| -14% | -$9.59K | ﹤0.01% | 3502 |
|
2022
Q2 | $60K | Buy |
2,914
+329
| +13% | +$6.77K | ﹤0.01% | 3671 |
|
2022
Q1 | $92K | Sell |
2,585
-505
| -16% | -$18K | ﹤0.01% | 3568 |
|
2021
Q4 | $84K | Buy |
3,090
+529
| +21% | +$14.4K | ﹤0.01% | 3703 |
|
2021
Q3 | $111K | Sell |
2,561
-39
| -2% | -$1.69K | ﹤0.01% | 3798 |
|
2021
Q2 | $129K | Buy |
+2,600
| New | +$129K | ﹤0.01% | 3962 |
|
2020
Q1 | – | Sell |
-1,285
| Closed | -$15K | – | 4390 |
|
2019
Q4 | $15K | Buy |
+1,285
| New | +$15K | ﹤0.01% | 4198 |
|
2019
Q3 | – | Sell |
-20
| Closed | – | – | 4756 |
|
2019
Q2 | $0 | Sell |
20
-538
| -96% | – | ﹤0.01% | 4931 |
|
2019
Q1 | $82K | Buy |
+558
| New | +$82K | ﹤0.01% | 4216 |
|